Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Loftus

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Gut|December 14, 2004
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitisE V Loftus, G C Harewood, C G Loftus, et al.
The American Journal of Gastroenterology|July 14, 2000
Early measles virus infection is associated with the development of inflammatory bowel diseaseD S Pardi, W J Tremaine, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|August 13, 2015
Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's diseaseS Singh, N S Ding, K L Mathis, et al.
Gut|May 2, 2006
Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive proteinJ F Colombel, C A Solem, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: Effectiveness of split-dose certolizumab pegol for Crohn's diseaseS V Kane, B Neis, B D Becker, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Gut|October 16, 2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideP W Lowry, C L Franklin, A L Weaver, et al.
Inflammatory Bowel Diseases|March 16, 2012
Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experienceS V Kane, S Horst, W J Sandborn, et al.
Inflammatory Bowel Diseases|August 23, 2001
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's diseaseW J Sandborn, E V Loftus, J F Colombel, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trialW J Sandborn, B E Sands, D C Wolf, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Gut|December 14, 2004
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitisE V Loftus, G C Harewood, C G Loftus, et al.
The American Journal of Gastroenterology|July 14, 2000
Early measles virus infection is associated with the development of inflammatory bowel diseaseD S Pardi, W J Tremaine, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|August 13, 2015
Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's diseaseS Singh, N S Ding, K L Mathis, et al.
Gut|May 2, 2006
Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive proteinJ F Colombel, C A Solem, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: Effectiveness of split-dose certolizumab pegol for Crohn's diseaseS V Kane, B Neis, B D Becker, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Gut|October 16, 2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideP W Lowry, C L Franklin, A L Weaver, et al.
Inflammatory Bowel Diseases|March 16, 2012
Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experienceS V Kane, S Horst, W J Sandborn, et al.
Inflammatory Bowel Diseases|August 23, 2001
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's diseaseW J Sandborn, E V Loftus, J F Colombel, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trialW J Sandborn, B E Sands, D C Wolf, et al.
Pageof 8